The landscape of somatic genetic alterations in breast cancers from CHEK2 germline mutation carriers

被引：0
|
作者：
Kumar, R. [1 ]
Pei, X. [1 ]
Selenica, P. [1 ]
Wen, H. Y. [1 ]
Powell, S. [1 ]
Robson, M. [1 ]
Riaz, N. [1 ]
Reis-Filho, J. S. [1 ]
Weigelt, B. [1 ]
Mandelker, D. [1 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
来源：
CANCER RESEARCH | 2019年 / 79卷 / 04期
关键词：
D O I：
10.1158/1538-7445.SABCS18-P4-04-01
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P4-04-01
引用
收藏
页数：2
相关论文
共 50 条
  • [31] The somatic mutation landscape of germline CHEK2-altered prostate cancer.
    Nizialek, Emily
    Lotan, Tamara L.
    Isaacs, William B.
    Yegnasubramanian, Srinivasan
    Paller, Channing Judith
    Antonarakis, Emmanuel S.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [32] CHEK2 mutation and hereditary breast cancer
    Bogdanova, Natalia
    Feshchenko, Sergei
    Cybulski, Cezary
    Doerk, Thilo
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (19) : E26 - E26
  • [33] Clinicopathologic and genetic analysis of invasive breast carcinomas in women with germline CHEK2 variants
    Christopher J. Schwartz
    Nikka Khorsandi
    Amie Blanco
    Rita A. Mukhtar
    Yunn-Yi Chen
    Gregor Krings
    [J]. Breast Cancer Research and Treatment, 2024, 204 : 171 - 179
  • [34] Clinicopathologic and genetic analysis of invasive breast carcinomas in women with germline CHEK2 variants
    Schwartz, Christopher J.
    Khorsandi, Nikka
    Blanco, Amie
    Mukhtar, Rita A.
    Chen, Yunn-Yi
    Krings, Gregor
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2024, 204 (01) : 171 - 179
  • [35] Identification of two poorly prognosed ovarian carcinoma subtypes associated with CHEK2 germline mutation and non-CHEK2 somatic mutation gene signatures
    Ow, Ghim Siong
    Ivshina, Anna V.
    Fuentes, Gloria
    Kuznetsov, Vladimir A.
    [J]. CELL CYCLE, 2014, 13 (14) : 2262 - 2280
  • [36] Profiling of the genetic features of patients with breast, ovarian, colorectal and extracolonic cancers: Association to CHEK2 and PALB2 germline mutations
    Infante, Mar
    Arranz-Ledo, Monica
    Lastra, Enrique
    Olaverri, Amaya
    Ferreira, Raquel
    Orozco, Marta
    Hernandez, Lara
    Martinez, Noemi
    Duran, Mercedes
    [J]. CLINICA CHIMICA ACTA, 2024, 552
  • [37] The risk of breast cancer in women with a CHEK2 mutation
    Cezary Cybulski
    Dominika Wokołorczyk
    Anna Jakubowska
    Tomasz Huzarski
    Tomasz Byrski
    Jacek Gronwald
    Tadeusz Dębniak
    Bohdan Górski
    Steven A Narod
    Jan Lubiński
    [J]. Hereditary Cancer in Clinical Practice, 10 (Suppl 1)
  • [38] Case Report of an Adrenocortical Carcinoma Associated With Germline CHEK2 Mutation
    Xie, Changqing
    Tanakchi, Sally
    Raygada, Margarita
    Davis, Jeremy L.
    Del Rivero, Jaydira
    [J]. JOURNAL OF THE ENDOCRINE SOCIETY, 2019, 3 (01): : 284 - 290
  • [39] Breast cancer risk is similar for CHEK2 founder and non-founder mutation carriers
    Leedom, Tracey P.
    LaDuca, Holly
    McFarland, Rachel
    Li, Shuwei
    Dolinsky, Jill S.
    Chao, Elizabeth C.
    [J]. CANCER GENETICS, 2016, 209 (09) : 403 - 407
  • [40] Germline mutation of CHEK2 in neurofibromatosis 1 and 2 Two case reports
    Li, Qiang
    Zhao, Feilong
    Ju, Yan
    [J]. MEDICINE, 2018, 97 (23)
12345